Brandi Roberts - 08 Feb 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc.

Reporting relationship: CFO
Issuer ticker: N/A
Reported as of: 08 Feb 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Feb 2024, 16:10:01 UTC
Prior SEC filing: 04 Dec 2023
Next SEC filing: 22 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Andrew J. Cronauer, Attorney-In-Fact

Key filing fact

Brandi Roberts filed Form 4 for Longboard Pharmaceuticals, Inc. on 09 Feb 2024.

Key facts

This page summarizes Brandi Roberts's Form 4 filing for Longboard Pharmaceuticals, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Feb 2024, 16:10.

Change

Previous filing in this sequence was filed on 04 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LBPH transaction

Common Stock

Award

Transaction value: $0
Shares: +15,090
Change %
Price: $0.000000
Shares after: 15,090
Date: 08 Feb 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LBPH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +90,580
Change %
Price: $0.000000
Shares after: 90,580
Date: 08 Feb 2024
Ownership: Direct
Underlying class: Voting common stock
Underlying amount: 90,580
Exercise price: $19.32
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The amount represents restricted stock units that vest in four equal annual installments commencing on February 8, 2025. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.

Footnote F2

The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 8, 2024.